Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturers:
|
Synflorix Pneumococcal polysaccharide type 1 1mcg Pneumococcal polysaccharide type 14 1mcg Pneumococcal polysaccharide type 18C 3mcg Pneumococcal polysaccharide type 19F 3mcg Pneumococcal polysaccharide type 23F 1mcg Pneumococcal polysaccharide type 4 3mcg Pneumococcal polysaccharide type 5 1mcg Pneumococcal polysaccharide type 6B 1mcg Pneumococcal polysaccharide type 7F 1mcg Pneumococcal polysaccharide type 9V 1mcg Suspension for injection GlaxoSmithKline (NZ) Limited GlaxoSmithKline Biologicals SA, Rixensart, Belgium GlaxoSmithKline Biologicals (France), Saint-Amand-Les-Eaux, France
|
Dated this 15th day of September 2017.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).